• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[偏头痛预防筛查工具的开发]

[Development of a screening tool for migraine prophylaxis].

作者信息

Wissmann A, Feuersenger A, Gendolla A, Reuter U, Straube A, Evers S, May A, Peikert A, Pfaffenrath V, Staudenmayer H, Diener H-C

机构信息

Klinik für Neurologie, Universitätsklinikum Essen, Hufelandstr. 55, 45122 Essen.

出版信息

Schmerz. 2007 Oct;21(5):430-8. doi: 10.1007/s00482-007-0529-4.

DOI:10.1007/s00482-007-0529-4
PMID:17323045
Abstract

The aim of the present study was to develop a screening tool to aid non-headache specialists, like general practitioners, in deciding whether migraine prophylaxis in the individual migraine patient is useful or not. The first step was the development of a questionnaire, consisting of 10 items, which was filled in by 132 migraineurs who called on neurologists or headache experts. Independently, the physicians filled in another questionnaire to answer the question of whether they decided to prescribe migraine prophylaxis and if they had, to give their reasons for doing so. Using logistic regression analysis, we identified the three questions which had the most influence on the decision regarding prophylaxis in the data set. As results, we identified the following three questions: 1. Do you suffer from migraine on more than 3 days/month? 2. Do you have to rest in bed while experiencing a migraine attack? 3. Do you have to take medication against migraine on more than 5 days/month? Validation of this reduced questionnaire is currently ongoing and involves 150 migraine patients of general practitioners.

摘要

本研究的目的是开发一种筛查工具,以帮助非头痛专科医生,如全科医生,判断个体偏头痛患者进行偏头痛预防性治疗是否有用。第一步是编制一份包含10个条目的问卷,由132名拜访神经科医生或头痛专家的偏头痛患者填写。医生们独立填写另一份问卷,以回答他们是否决定开具偏头痛预防性治疗药物,以及如果开具了,给出这样做的理由。使用逻辑回归分析,我们在数据集中确定了对预防性治疗决策影响最大的三个问题。结果,我们确定了以下三个问题:1. 你每月偏头痛发作超过3天吗?2. 偏头痛发作时你必须卧床休息吗?3. 你每月服用抗偏头痛药物超过5天吗?这份精简后的问卷目前正在进行验证,涉及150名全科医生的偏头痛患者。

相似文献

1
[Development of a screening tool for migraine prophylaxis].[偏头痛预防筛查工具的开发]
Schmerz. 2007 Oct;21(5):430-8. doi: 10.1007/s00482-007-0529-4.
2
Diagnosis and development of screening items for migraine in neurological practice in Taiwan.台湾神经科临床中偏头痛筛查项目的诊断与发展
J Formos Med Assoc. 2008 Jun;107(6):485-94. doi: 10.1016/S0929-6646(08)60157-6.
3
Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.识别需要改变当前急性偏头痛治疗方案的患者:当前治疗偏头痛评估(Migraine-ACT)问卷。
Curr Med Res Opin. 2004 Jul;20(7):1125-35. doi: 10.1185/030079904125004079.
4
Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.两种中心、随机的偏头痛预防方案对照研究,比较了采用预防性氟伐曲坦或每日托吡酯的方案:研究和临床意义。
Headache. 2012 May;52(5):749-64. doi: 10.1111/j.1526-4610.2011.02054.x. Epub 2011 Dec 21.
5
Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.A型肉毒杆菌毒素用于因依从性问题而导致口服预防性治疗失败的偏头痛患者的预防性治疗。
Headache. 2008 Jun;48(6):900-13. doi: 10.1111/j.1526-4610.2007.00953.x. Epub 2007 Nov 28.
6
Patients' management of migraine and chronic daily headache: a study of the members of the Migraine Action Association (United Kingdom).偏头痛和慢性每日头痛患者的管理:对偏头痛行动协会(英国)成员的一项研究。
Headache. 2005 May;45(5):571-81. doi: 10.1111/j.1526-4610.2005.05111.x.
7
Implementation and evaluation of existing guidelines on the use of neurophysiological tests in non-acute migraine patients: a questionnaire survey of neurologists and primary care physicians.非急性偏头痛患者神经生理学检查使用的现有指南的实施与评估:对神经科医生和初级保健医生的问卷调查
Eur J Neurol. 2009 Aug;16(8):937-42. doi: 10.1111/j.1468-1331.2009.02630.x. Epub 2009 Apr 23.
8
Results of screening with the brief headache screen compared with a modified IDMigraine.使用简短头痛筛查与改良版ID偏头痛筛查的结果比较。
Headache. 2008 Mar;48(3):385-94. doi: 10.1111/j.1526-4610.2007.00946.x. Epub 2007 Nov 20.
9
Screening for migraine in the general population: validation of a simple questionnaire.普通人群中偏头痛的筛查:一份简易问卷的验证
Cephalalgia. 1998 Jul-Aug;18(6):342-8. doi: 10.1046/j.1468-2982.1998.1806342.x.
10
Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.识别需要改变当前急性偏头痛治疗方案的患者:当前治疗偏头痛评估(Migraine-ACT)问卷
Neurol Sci. 2004 Oct;25 Suppl 3:S276-8. doi: 10.1007/s10072-004-0308-2.

引用本文的文献

1
[Alternatives to beta blockers in preventive migraine treatment].[预防性偏头痛治疗中β受体阻滞剂的替代药物]
Nervenarzt. 2008 Oct;79(10):1135-6, 1138-40, 1142-3. doi: 10.1007/s00115-008-2522-2.

本文引用的文献

1
Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.在一家三级医疗头痛中心15年期间报告的与可能的药物过度使用性头痛相关的药物。
Headache. 2006 May;46(5):766-72. doi: 10.1111/j.1526-4610.2006.00442.x.
2
Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.托吡酯每日100毫克用于偏头痛预防:双盲随机对照试验的汇总分析
Int J Clin Pract. 2005 Aug;59(8):961-8. doi: 10.1111/j.1368-5031.2005.00612.x.
3
Cost of migraine and other headaches in Europe.
欧洲偏头痛及其他头痛疾病的成本。
Eur J Neurol. 2005 Jun;12 Suppl 1:59-62. doi: 10.1111/j.1468-1331.2005.01192.x.
4
[Faster, higher, further. Current thinking on acute and prophylactic treatment of migraine].[更快、更高、更远。偏头痛急性和预防性治疗的当前思路]
Schmerz. 2004 Oct;18(5):398-403. doi: 10.1007/s00482-004-0362-y.
5
A self-administered screener for migraine in primary care: The ID Migraine validation study.基层医疗中偏头痛的自我管理筛查工具:ID偏头痛验证研究。
Neurology. 2003 Aug 12;61(3):375-82. doi: 10.1212/01.wnl.0000078940.53438.83.
6
[Therapy of the acute migraine attack and migraine prophylaxis. Recommendation of the "Deutsche Migräne- und Kopfschmerz-Gesellschaft].
Schmerz. 2000 Aug;14(4):269-83. doi: 10.1007/s004820000041.
7
[Prophylactic drug management of migraine].[偏头痛的预防性药物治疗]
Schmerz. 2002 Jun;16(3):223-40. doi: 10.1007/s00482-002-0146-1.
8
Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED]: report of the Quality Standards Subcommittee of the American Academy of Neurology.实践参数:偏头痛循证指南(循证综述)[已退休]:美国神经病学学会质量标准小组委员会报告
Neurology. 2000 Sep 26;55(6):754-62. doi: 10.1212/wnl.55.6.754.
9
Multispecialty consensus on diagnosis and treatment of headache.头痛诊断与治疗的多专业共识
Neurology. 2000 Apr 25;54(8):1553. doi: 10.1212/wnl.54.8.1553.
10
The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society.德国头痛病流行病学:基于国际头痛协会头痛分类法对代表性样本进行的全国性调查。
Cephalalgia. 1994 Apr;14(2):97-106. doi: 10.1046/j.1468-2982.1994.1402097.x.